Kwang Soo Cheong

Corporate Officer/Principal at Carey Business School

63 year

Consumer Services

Health Technology

Profile

Kwang Soo Cheong is currently an Associate Professor at Carey Business School since 2005.
He previously worked as an Independent Director at Rexahn Pharmaceuticals, Inc. He also served as an Assistant Professor-Economics at the University of Hawai'i at Hilo from 1994 to 2001.
Dr. Cheong holds a doctorate degree from Stanford University and has completed his undergraduate and graduate studies at Seoul National University.

Kwang Soo Cheong active positions

Companies	Position	Start
Carey Business School	Corporate Officer/Principal	01/01/2001

All active positions of Kwang Soo Cheong

Former positions of Kwang Soo Cheong

Companies	Position	End
University of Hawai'i at Hilo University of Hawai'i at Hilo Other Consumer ServicesConsumer Services University of Hawai'i at Hilo engages in the provision of services relating to higher education. It offers bachelor’s degrees, minors, master’s degrees, doctoral degrees, certificate programs, graduate certificate programs, and distance learning. The company was founded in 1947 and is headquartered in Hilo, HI.	Corporate Officer/Principal	01/01/2001
REXAHN PHARMACEUTICALS, INC.	Director/Board Member	-

See the detail of Kwang Soo Cheong's experience

Training of Kwang Soo Cheong

Seoul National University	Graduate Degree
Stanford University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kwang Soo Cheong's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Rexahn Pharmaceuticals, Inc. Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.	Health Technology